Dr. Sushma Bharadwaj, MD

Dr. Bharadwaj practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Bharadwaj's NPI, 1265745731, was assigned on July 26, 2010. Dr. Bharadwaj graduated from Kasturba Med College Mangalore in 2006. Dr. Bharadwaj holds California license C168707.

Dr. Bharadwaj's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Bharadwaj's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Bharadwaj to 1 more hospital and 1 medical group, each named with a free account. Dr. Bharadwaj's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bharadwaj practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bharadwaj's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Bharadwaj is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bharadwaj's licenses on file in 3 states: California, Maine and Illinois.

Dmand AI lists gastroenteritis, kidney failure and rash among the conditions Dr. Bharadwaj treats.

CMS data shows 331 Medicare services from Dr. Bharadwaj across 2 procedure codes in 2024, for 87 Medicare patients. Medicare paid $39,651 for them.

CMS counts 87 Medicare patients who saw Dr. Bharadwaj in 2024. The largest group is 65 to 74, with 50 patients. 68% of them have high cholesterol, and 67% have high blood pressure. 32% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bharadwaj's median patient age at 61, with 44% women.

In 2024, Dr. Bharadwaj wrote 317 Medicare Part D claims for 39 patients. 88% of them were for generic drugs. CMS names the drug for 228 of them, across 8 drugs with 11 or more claims each, at $57,789 in total drug cost. In 2023, CMS named 106 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bharadwaj for performance year 2024, reported as part of a group. Dr. Bharadwaj accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bharadwaj as offering telehealth.

Dmand AI links 21 papers to Dr. Bharadwaj, published from 2020 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Immunotherapy, Adoptive, Receptors, Chimeric Antigen and Antigens, CD19. Dr. Bharadwaj has published most often in Blood Adv. Dr. Bharadwaj's most frequent co-authors are Matthew Joshua Frank, MD, PhD, David Bernard Miklos, MD, PhD and Saurabh Dahiya, MD.

CMS Open Payments shows 31 general payments to Dr. Bharadwaj from 12 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 53% of the total. Adaptive Biotechnologies Corporation paid the most, $1,606.

Dr. Bharadwaj graduated from Kasturba Med College Mangalore in 2006.

Dr. Bharadwaj is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.